These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3124456)

  • 1. Prospective controlled study of androgen therapy in the anemia of chronic renal disease: effects on iron kinetics.
    Solomon LR; Hendler ED
    Acta Haematol; 1988; 79(1):12-9. PubMed ID: 3124456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective controlled study of androgen effects on red cell oxygen transport and work capacity in chronic hemodialysis patients.
    Hendler ED; Solomon LR
    Acta Haematol; 1990; 83(1):1-8. PubMed ID: 2105563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen therapy for anaemia of chronic renal failure. Indications in the erythropoietin era.
    Teruel JL; Aguilera A; Marcen R; Navarro Antolin J; Garcia Otero G; Ortuño J
    Scand J Urol Nephrol; 1996 Oct; 30(5):403-8. PubMed ID: 8936631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anemia of chronic renal insufficiency. II. Effect of androgen therapy in 17 subjects treated with periodic hemodialysis].
    Najean Y; Eberlin A; Delons S; Naret C; Petrover M; Aubert P
    Presse Med; 1983 Apr; 12(18):1159-61. PubMed ID: 6221284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anemia in terminal kidney insufficiency: ferrokinetics, erythrocyte survival times and erythrocyte enzymes in chronic dialysis patients].
    Junkers K; Jontofsohn R; Meuret G; Blume KG; Heinze V
    Nucl Med (Stuttg); 1975 Dec; 14(4):355-64. PubMed ID: 1215213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis.
    Hendler ED; Goffinet JA; Ross S; Longnecker RE; Bakovic V
    N Engl J Med; 1974 Nov; 291(20):1046-51. PubMed ID: 4606387
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of nandrolone decanoate on nutritional parameters in hemodialysis patients.
    Barton Pai A; Chretien C; Lau AH
    Clin Nephrol; 2002 Jul; 58(1):38-46. PubMed ID: 12141405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
    Navarro JF; Mora C; Macía M; García J
    Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of erythropoiesis activity during hemodialysis therapy by soluble transferrin receptor levels and ferrokinetic measurements.
    Lorenzo JD; Rodríguez MM; Martín SS; Romo JM
    Am J Kidney Dis; 2001 Mar; 37(3):550-6. PubMed ID: 11228179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.
    Berns JS; Rudnick MR; Cohen RM
    Clin Nephrol; 1992 May; 37(5):264-7. PubMed ID: 1606777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nandrolone decanoate reduces serum lipoprotein(a) concentrations in hemodialysis patients.
    Teruel JL; Lasuncion MA; Rivera M; Aguilera A; Ortega H; Tato A; Marcen R; Ortuño J
    Am J Kidney Dis; 1997 Apr; 29(4):569-75. PubMed ID: 9100047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nandrolone decanoate therapy for patients receiving hemodialysis. A controlled study.
    Williams JS; Stein JH; Ferris TF
    Arch Intern Med; 1974 Aug; 134(2):289-92. PubMed ID: 4602048
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of nandrolone decanoate as an adjuvant for erythropoietin dose reduction in treating anemia in patients on hemodialysis.
    Sheashaa H; Abdel-Razek W; El-Husseini A; Selim A; Hassan N; Abbas T; El-Askalani H; Sobh M
    Nephron Clin Pract; 2005; 99(4):c102-6. PubMed ID: 15703460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen therapy for anemia in renal failure.
    Ryabov SI; Shostka GD; Vinogradova TV
    Int Urol Nephrol; 1980; 12(2):161-7. PubMed ID: 7228571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nandrolone decanoate therapy for anemia in patients on haemodialysis.
    Balaji HD; Hariharan S; Jacob CK; Kirubakaran MG; Shastry JC
    J Assoc Physicians India; 1988 Nov; 36(11):677-8. PubMed ID: 3074079
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma erythropoietin levels in patients undergoing long-term hemodialysis.
    Raich PC; Korst DR
    Arch Pathol Lab Med; 1978 Feb; 102(2):73-5. PubMed ID: 579968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shortened red blood cell lifespan is related to the dose of erythropoiesis-stimulating agents requirement in patients on hemodialysis.
    Sato Y; Mizuguchi T; Shigenaga S; Yoshikawa E; Chujo K; Minakuchi J; Kawashima S
    Ther Apher Dial; 2012 Dec; 16(6):522-8. PubMed ID: 23190511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia.
    Schoorl M; Schoorl M; Nubé MJ; Bartels PC
    Clin Lab; 2006; 52(11-12):621-9. PubMed ID: 17175894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study.
    Teruel JL; Marcen R; Navarro-Antolin J; Aguilera A; Fernandez-Juarez G; Ortuño J
    J Am Soc Nephrol; 1996 Jan; 7(1):140-4. PubMed ID: 8808121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.